The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study
Recruiting · NCT06064149 · Interventional (participants receive a specific treatment) · Lead sponsor: Vivek Narayan
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The overarching goal of this trial is to develop mechanisms to improve cardiovascular care among such prostate cancer patients receiving ADT by increasing patient awareness of individualized cardiovascular risk estimates and mitigation opportunities. Patients will be given access to a web-based quality improvement tool to educate patients of cardiovascular risks in prostate cancer and to inform them of their individualized, estimated cardiovascular risk and guideline-based risk mitigation recommendations. The study will assess the feasibility of this web-based application as a cardiovascular education tool for patients with prostate cancer. The study will also evaluate if completion of the web-based tool improves cardiovascular care access and risk mitigation for patients with prostate cancer.
Who can take part
Inclusion criteria
- Men with prostate cancer \> 18 years of age who are currently receiving or will be receiving treatment with ≥ 6 months of ADT
- Patients must be able to read and understand English.
Exclusion criteria
- n/a
Where it is running
1 location listed across 1 US state.
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia, Pennsylvania, United States